Amedisys Debt to Equity Ratio 2010-2025 | AMED

Current and historical debt to equity ratio values for Amedisys (AMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Amedisys debt/equity for the three months ending March 31, 2025 was 0.27.
Amedisys Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.94B $1.25B 0.76
2024-12-31 $0.96B $1.18B 0.81
2024-09-30 $0.94B $1.20B 0.78
2024-06-30 $0.94B $1.18B 0.80
2024-03-31 $0.95B $1.14B 0.83
2023-12-31 $0.94B $1.12B 0.84
2023-09-30 $0.93B $1.09B 0.85
2023-06-30 $0.92B $1.06B 0.87
2023-03-31 $0.81B $1.13B 0.72
2022-12-31 $0.87B $1.11B 0.79
2022-09-30 $0.91B $1.07B 0.85
2022-06-30 $0.96B $1.04B 0.93
2022-03-31 $0.89B $1.02B 0.87
2021-12-31 $0.88B $0.98B 0.90
2021-09-30 $0.99B $0.95B 1.04
2021-06-30 $0.72B $0.88B 0.83
2021-03-31 $0.78B $0.79B 0.99
2020-12-31 $0.76B $0.81B 0.93
2020-09-30 $0.85B $0.76B 1.12
2020-06-30 $0.92B $0.72B 1.28
2020-03-31 $0.76B $0.68B 1.12
2019-12-31 $0.62B $0.64B 0.97
2019-09-30 $0.61B $0.60B 1.01
2019-06-30 $0.64B $0.56B 1.14
2019-03-31 $0.66B $0.52B 1.27
2018-12-31 $0.23B $0.48B 0.49
2018-09-30 $0.28B $0.45B 0.63
2018-06-30 $0.34B $0.41B 0.84
2018-03-31 $0.29B $0.55B 0.53
2017-12-31 $0.30B $0.52B 0.58
2017-09-30 $0.29B $0.51B 0.56
2017-06-30 $0.31B $0.49B 0.63
2017-03-31 $0.27B $0.48B 0.57
2016-12-31 $0.27B $0.46B 0.59
2016-09-30 $0.28B $0.45B 0.62
2016-06-30 $0.28B $0.43B 0.66
2016-03-31 $0.30B $0.41B 0.72
2015-12-31 $0.27B $0.41B 0.66
2015-09-30 $0.27B $0.39B 0.69
2015-06-30 $0.27B $0.38B 0.70
2015-03-31 $0.26B $0.37B 0.70
2014-12-31 $0.27B $0.40B 0.68
2014-09-30 $0.30B $0.38B 0.78
2014-06-30 $0.34B $0.37B 0.91
2014-03-31 $0.36B $0.36B 1.00
2013-12-31 $0.35B $0.37B 0.95
2013-09-30 $0.38B $0.38B 1.00
2013-06-30 $0.24B $0.47B 0.51
2013-03-31 $0.25B $0.46B 0.54
2012-12-31 $0.28B $0.45B 0.61
2012-09-30 $0.30B $0.57B 0.53
2012-06-30 $0.32B $0.54B 0.59
2012-03-31 $0.33B $0.53B 0.61
2011-12-31 $0.34B $0.52B 0.65
2011-09-30 $0.34B $0.51B 0.65
2011-06-30 $0.41B $0.93B 0.44
2011-03-31 $0.42B $0.90B 0.47
2010-12-31 $0.42B $0.88B 0.48
2010-09-30 $0.42B $0.85B 0.49
2010-06-30 $0.44B $0.83B 0.53
2010-03-31 $0.44B $0.78B 0.56
2009-12-31 $0.44B $0.74B 0.59
2009-09-30 $0.45B $0.69B 0.65
2009-06-30 $0.44B $0.64B 0.69
2009-03-31 $0.49B $0.60B 0.82
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.205B $2.348B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.083B 19.79
Encompass Health (EHC) United States $12.188B 25.84
DaVita (DVA) United States $10.642B 14.96
Chemed (CHE) United States $8.153B 25.62
Elanco Animal Health (ELAN) United States $6.710B 14.37
Option Care Health (OPCH) United States $5.282B 23.55
RadNet (RDNT) United States $4.185B 265.62
Addus HomeCare (ADUS) United States $2.098B 23.04
LifeStance Health (LFST) United States $1.975B 0.00
Astrana Health (ASTH) United States $1.497B 37.08
U.S Physical Therapy (USPH) United States $1.201B 31.00
Pennant (PNTG) United States $1.003B 36.82
Aveanna Healthcare Holdings (AVAH) United States $0.970B 55.22
Atai Life Sciences (ATAI) Germany $0.423B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.038B 0.00
Ontrak (OTRK) United States $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00